CADL: Candel Therapeutics, Inc. Stock

by  •  • Comments Off on CADL: Candel Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 224.37
Enterprise Value ($M) 134.21
Book Value ($M) 66.33
Book Value / Share 1.40
Price / Book 3.38
NCAV ($M) 63.27
NCAV / Share 1.34
Price / NCAV 3.55

Profitability (mra)
Return on Invested Capital (ROIC) -0.69
Return on Assets (ROA) -1.77
Return on Equity (ROE) -9.23

Liquidity (mrq)
Quick Ratio 2.77
Current Ratio 2.77

Balance Sheet (mrq) ($M)
Current Assets 103.80
Assets 106.87
Liabilities 40.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -32.63
Net Income -55.18

Cash Flow Statement (mra) ($M)
Cash From Operations -27.02
Cash from Investing -0.02
Cash from Financing 94.28

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Northpond Ventures, LP 0.00 -100.00
02-14 13G Baker Bros. Advisors Lp 6.80
02-07 13G Fmr Llc 9.30 431.94
02-07 13G/A CVI Investments, Inc. 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 264,392 656,484 40.27
2025-05-07 203,729 655,684 31.07
2025-05-06 411,068 933,496 44.04
2025-05-05 399,249 962,144 41.50

(click for more detail)

Similar Companies
BCAB – BioAtla, Inc. BHST – BioHarvest Sciences Inc.
BTMD – biote Corp. CARM – Carisma Therapeutics, Inc.
CHRS – Coherus BioSciences, Inc.


Financial data and stock pages provided by
Fintel.io